Literature DB >> 27515410

Exploration of the conformational landscape in pregnane X receptor reveals a new binding pocket.

Aneesh Chandran1,2, Saraswathi Vishveshwara3.   

Abstract

Ligand-regulated pregnane X receptor (PXR), a member of the nuclear receptor superfamily, plays a central role in xenobiotic metabolism. Despite its critical role in drug metabolism, PXR activation can lead to adverse drug-drug interactions and early stage metabolism of drugs. Activated PXR can induce cancer drug resistance and enhance the onset of malignancy. Since promiscuity in ligand binding makes it difficult to develop competitive inhibitors targeting PXR ligand binding pocket (LBP), it is essential to identify allosteric sites for effective PXR antagonism. Here, molecular dynamics (MD) simulation studies unravelled the existence of two different conformational states, namely "expanded" and "contracted", in apo PXR ligand binding domain (LBD). Ligand binding events shifted this conformational equilibrium and locked the LBD in a single "ligand-adaptable" conformational state. Ensemble-based computational solvent mapping identified a transiently open potential small molecule binding pocket between α5 and α8 helices, named "α8 pocket", whose opening-closing mechanism directly correlated with the conformational shift in LBD. A virtual hit identified through structure-based virtual screening against α8 pocket locks the pocket in its open conformation. MD simulations further revealed that the presence of small molecule at allosteric site disrupts the LBD dynamics and locks the LBD in a "tightly-contracted" conformation. The molecular details provided here could guide new structural studies to understand PXR activation and antagonism.
© 2016 The Protein Society.

Entities:  

Keywords:  fragment-based mapping; free energy landscape; molecular dynamics simulations; pregnane X receptor; protein structure networks; virtual screening

Mesh:

Substances:

Year:  2016        PMID: 27515410      PMCID: PMC5079256          DOI: 10.1002/pro.3012

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  46 in total

1.  WHAT IF: a molecular modeling and drug design program.

Authors:  G Vriend
Journal:  J Mol Graph       Date:  1990-03

Review 2.  Principles for modulation of the nuclear receptor superfamily.

Authors:  Hinrich Gronemeyer; Jan-Ake Gustafsson; Vincent Laudet
Journal:  Nat Rev Drug Discov       Date:  2004-11       Impact factor: 84.694

3.  An automated approach to network features of protein structure ensembles.

Authors:  Moitrayee Bhattacharyya; Chanda R Bhat; Saraswathi Vishveshwara
Journal:  Protein Sci       Date:  2013-10       Impact factor: 6.725

4.  Understanding protein structure from a percolation perspective.

Authors:  Dhruba Deb; Saraswathi Vishveshwara; Smitha Vishveshwara
Journal:  Biophys J       Date:  2009-09-16       Impact factor: 4.033

5.  Crystal structure of the PXR-T1317 complex provides a scaffold to examine the potential for receptor antagonism.

Authors:  Yu Xue; Esther Chao; William J Zuercher; Timothy M Willson; Jon L Collins; Matthew R Redinbo
Journal:  Bioorg Med Chem       Date:  2006-12-20       Impact factor: 3.641

6.  Human pregnane X receptor antagonists and agonists define molecular requirements for different binding sites.

Authors:  Sean Ekins; Cheng Chang; Sridhar Mani; Matthew D Krasowski; Erica J Reschly; Manisha Iyer; Vladyslav Kholodovych; Ni Ai; William J Welsh; Michael Sinz; Peter W Swaan; Rachana Patel; Kenneth Bachmann
Journal:  Mol Pharmacol       Date:  2007-06-18       Impact factor: 4.436

7.  Putative role of the orphan nuclear receptor SXR (steroid and xenobiotic receptor) in the mechanism of CYP3A4 inhibition by xenobiotics.

Authors:  Akira Takeshita; Manabu Taguchi; Noriyuki Koibuchi; Yasunori Ozawa
Journal:  J Biol Chem       Date:  2002-06-18       Impact factor: 5.157

8.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.

Authors:  Garrett M Morris; Ruth Huey; William Lindstrom; Michel F Sanner; Richard K Belew; David S Goodsell; Arthur J Olson
Journal:  J Comput Chem       Date:  2009-12       Impact factor: 3.376

9.  Identification of potential small molecule binding pockets on Rho family GTPases.

Authors:  Juan Manuel Ortiz-Sanchez; Sara E Nichols; Jacqueline Sayyah; Joan Heller Brown; J Andrew McCammon; Barry J Grant
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

10.  Fpocket: an open source platform for ligand pocket detection.

Authors:  Vincent Le Guilloux; Peter Schmidtke; Pierre Tuffery
Journal:  BMC Bioinformatics       Date:  2009-06-02       Impact factor: 3.169

View more
  4 in total

1.  Sequence Variations in pxr (nr1i2) From Zebrafish (Danio rerio) Strains Affect Nuclear Receptor Function.

Authors:  Roger Lille-Langøy; Odd André Karlsen; Line Merethe Myklebust; Jared V Goldstone; Astrid Mork-Jansson; Rune Male; Bruce Blumberg; John J Stegeman; Anders Goksøyr
Journal:  Toxicol Sci       Date:  2019-03-01       Impact factor: 4.849

2.  Exploration of inositol 1,4,5-trisphosphate (IP3) regulated dynamics of N-terminal domain of IP3 receptor reveals early phase molecular events during receptor activation.

Authors:  Aneesh Chandran; Xavier Chee; David L Prole; Taufiq Rahman
Journal:  Sci Rep       Date:  2019-02-21       Impact factor: 4.379

3.  Discrepancy in interactions and conformational dynamics of pregnane X receptor (PXR) bound to an agonist and a novel competitive antagonist.

Authors:  Azam Rashidian; Enni-Kaisa Mustonen; Thales Kronenberger; Matthias Schwab; Oliver Burk; Stefan A Laufer; Tatu Pantsar
Journal:  Comput Struct Biotechnol J       Date:  2022-06-13       Impact factor: 6.155

4.  Gefitinib Inhibits Rifampicin-Induced CYP3A4 Gene Expression in Human Hepatocytes.

Authors:  Kodye L Abbott; Julia M Salamat; Patrick C Flannery; Chloe S Chaudhury; Aneesh Chandran; Saraswathi Vishveshwara; Sridhar Mani; Jianfeng Huang; Amit K Tiwari; Satyanarayana R Pondugula
Journal:  ACS Omega       Date:  2022-09-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.